SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Détails bibliographiques
Auteur principal:	Meem, Manila
Autres auteurs:	Akter, Dr. Raushanara
Format:	Thèse
Langue:	English
Publié:	Brac University 2023
Sujets:	Cancer SHP2 inhibitors Targeted therapy Catalytic inhibitor Allosteric inhibitor. Cancer research.
Accès en ligne:	http://hdl.handle.net/10361/18081

Documents similaires

A review on potential of PARP inhibitors in the treatment of prostate cancer
par: Islam, Saidul
Publié: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
par: Jahan, Nusrat
Publié: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
par: Flora, Sanzida Alam
Publié: (2024)

Immunotherapy in the Management of Lung Cancer
par: Tasnim, Humayra
Publié: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
par: Ratu, Tabassum
Publié: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
par: Emon, Kamrul Hasan
Publié: (2022)

Identification of FAP inhibitors using in silico simulation study
par: Deeba, Maliha Tasnim
Publié: (2018)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
par: Oshin, Sadia Afrin
Publié: (2021)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
par: Karim, Azrin
Publié: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
par: Mirza, Maisa Tasnim
Publié: (2023)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
par: Khan, Muidul Hasan
Publié: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
par: Haque, Mushfiqul
Publié: (2019)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
par: Islam, Nahidul
Publié: (2023)

A review on targeted therapies for lung cancer
par: Ashraf, Anushey
Publié: (2023)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
par: Afroza, Halima
Publié: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
par: Ishrat, Nowshin
Publié: (2024)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
par: Sorno, Rubina Haque
Publié: (2024)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
par: Mahin, Md. Tamjidur Rahman
Publié: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
par: Alam, Kazi Tasnuva
Publié: (2022)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
par: Fred, Namanda Rogers
Publié: (2021)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
par: Khandker, Tahia Anjum
Publié: (2024)

Synthesis and sar o acne medication
par: Naureen, Tasnia
Publié: (2024)

HPLC method development for the analysis of linagliptin
par: Mimiya, Ruhani Amrin
Publié: (2020)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
par: Paul, Pulock
Publié: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
par: Kamal, Tasnova
Publié: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
par: Tania, Umme
Publié: (2023)

Trend in approval of targeted biologics in the last two decades
par: Siddika, Khadiza
Publié: (2024)

Breast cancer therapy through Liposomal drug delivery system
par: Ome, Nusrat Jahan
Publié: (2024)

Epigenetic therapy in cancer
par: Abid, Md. Shadman Ridwan
Publié: (2021)

A review on triple-negative breast cancer and its potential treatment
par: Niasa, Jannatul Ferdous
Publié: (2023)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
par: Razna, Amrin Islam
Publié: (2019)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
par: Chakraborty, Anuradha
Publié: (2024)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
par: Nahar, Kamrun
Publié: (2023)

The impact of cell penetrating peptides in prospective cancer therapy: a review
par: Nashrah, Zannatul
Publié: (2023)

A review on the recent advancements on nanoparticles drug delivery approaches in anti-cancer treatment
par: Hoque, Syeda Mehren
Publié: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
par: Parvez, Safi
Publié: (2023)

Statistics and informatics in molecular cancer research

A comprehensive review on drug repurposing in cancer treatment
par: Sarkar, Onusree
Publié: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
par: Hasan, Amit
Publié: (2024)

Art therapy to improve quality of life of cancer patients and their carers in Bangladesh
par: Dowla, Rumana, et autres
Publié: (2022)